Lifecore Biomedical Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022	May '21 May 30, 2021
Net Income	-38.72	12.01	-99.56	-116.72	-32.29
Depreciation & Amortization	8.03	7.95	12.68	17.66	5.2
Other Amortization	-	-	0.5	0.4	3.47
Loss (Gain) From Sale of Assets	7.78	0.02	-2.07	0.15	0.06
Asset Writedown & Restructuring Costs	-	-	0.64	5.19	10.14
Loss (Gain) From Sale of Investments	-	-	-	-	11.47
Stock-Based Compensation	10.16	6.2	3.61	2.61	3.36
Provision & Write-off of Bad Debts	-	-	0.16	-0.01	0.94
Other Operating Activities	17.25	-22.23	24.53	-7.25	-6.84
Change in Accounts Receivable	-5.17	-2.39	10.82	-6.14	5.78
Change in Inventory	7.69	0.86	-14.81	-2.18	-2.82
Change in Accounts Payable	-1.67	-6.68	16.04	9.34	-5.98
Change in Unearned Revenue	-	-	6.08	-0.02	0.43
Change in Other Net Operating Assets	-5.54	4.51	1.66	-4.11	12.36
Operating Cash Flow	-0.21	0.26	-17.44	-22.59	16.47
Capital Expenditures	-13.42	-18.4	-21.48	-29.94	-25.22
Sale of Property, Plant & Equipment	7	-	-	1.14	12.91
Divestitures	-	-	16.67	73.5	-
Other Investing Activities	-	-	-	35.26	-
Investing Cash Flow	-6.42	-18.4	-4.81	79.96	-12.31
Long-Term Debt Issued	128.57	149.59	181.45	75.11	270
Total Debt Issued	128.57	149.59	181.45	75.11	270
Long-Term Debt Repaid	-146.69	-147.42	-178.33	-130.52	-262.53
Total Debt Repaid	-146.69	-147.42	-178.33	-130.52	-262.53
Net Debt Issued (Repaid)	-18.12	2.17	3.12	-55.41	7.47
Issuance of Common Stock	23.85	0.72	4.82	-	-
Repurchase of Common Stock	-1.27	-0.15	-0.27	-0.79	-0.41
Other Financing Activities	1.97	4.77	-6.05	-0.82	-10.48
Financing Cash Flow	6.42	7.51	39.7	-57.02	-3.42
Net Cash Flow	-0.2	-10.63	17.45	0.35	0.74
Free Cash Flow	-13.62	-18.14	-38.92	-52.53	-8.75
Free Cash Flow Margin	-10.57%	-14.14%	-37.69%	-47.21%	-8.68%
Free Cash Flow Per Share	-0.39	-0.49	-1.30	-1.78	-0.30
Cash Interest Paid	1.91	2.73	31.02	16.89	13.22
Cash Income Tax Paid	0.05	0.07	0.02	0.44	-7.68
Levered Free Cash Flow	-28.83	-21.3	16.29	-26.82	-7.14
Unlevered Free Cash Flow	-15.19	-9.99	27.28	-17.15	-4.62
Change in Working Capital	-4.7	-3.7	19.79	-3.1	9.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.